Explore Business Standard
Associate Sponsors
Co-sponsor
Global tech giants Meta Platforms Inc. and WhatsApp told the Supreme Court on Monday that they will comply with the NCLAT's directions for extending the Competition Commission of India's (CCI) privacy and consent guidelines to advertising-related data. A bench of Chief Justice Surya Kant and Justices Joymalya Bagchi and Vipul M Pancholi was hearing appeals filed by the tech giants against the National Company Law Appellate Tribunal's (NCLAT) directions of December last year. The court is also seized of a cross-appeal filed by the CCI, assailing the NCLAT ruling to the extent that it allowed WhatsApp and Meta to continue sharing users' data for advertising purposes. "These applications essentially seek a direction for a stay of the impugned judgment of the NCLAT to the extent it approves the direction issued by the CCI directing Meta to comply with the impugned directions contained in the NCLAT order dated December 15, 2025, containing certain directions issued to Meta," the CJI ...
Competition Commission has imposed a fine of Rs 27.38 crore on Intel Corp for indulging in anti-competitive practices with respect to India-specific warranty policy for its boxed microprocessors. The penalty has been imposed on the company for abusing its dominant position in the market for Boxed Micro Processors (BMPs) for desktops in India. In a statement on Thursday, the Competition Commission of India (CCI) said the India-specific warranty policy was discriminatory in comparison with Intel's warranty policies in China, Australia and rest of the world. The Commission also found the policy to have limited the choice of consumers and parallel importers, and thereby causing an appreciable adverse effect on Indian consumers. Considering the fact that the India-specific warranty policy was in place for eight years, the regulator imposed the penalty translating to 8 per cent of the average relevant turnover of Intel. "However, considering the mitigating factors including the ...
Fair trade regulator CCI on Tuesday approved home-grown private equity firm ChrysCapital's proposal to acquire a stake in Nash Industries (I) Pvt Ltd. Mumbai-based ChrysCapital is acquiring stakes through its three affiliates, ChrysCapital Fund X, Two Infinity Partners and Blue Wave Investments Ltd. These entities invest in different sectors. "The proposed combination pertains to the acquisition by ChrysCapital Fund X, Two Infinity Partners and Blue Wave Investments Limited (collectively, the Acquirers), collectively, of certain equity share capital of Nash Industries (I) Private Limited (Target)," the Competition Commission of India (CCI) said in a release. Nash Industries is engaged in the business of box build solutions and metal stamping. The acquirers are private equity investors, belonging to the ChrysCapital Group. "Commission approves acquisition by ChrysCapital Fund X, Two Infinity Partners and Blue wave Investments Limited, collectively, of certain equity share capital in
Appellate tribunal NCLAT has said the fair trade regulator Competition Commission of India has no power to examine into the disputes related to patent matters. Dismissing an appeal against a CCI order, in which the regulator had closed a complaint against Swiss pharma major Vifor International (AG), a two-member NCLAT bench said the 'Patent Act will prevail over the Competition Act'. Citing the earlier judgments, NCLAT said: "Considering the judgment of the Delhi High Court in the case of Telefonaktiebolaget LM Ericsson (PUBL) and the Supreme Court in the SLP No. 25026/2023, it is apparent that the CCI lacks the power to examine the allegations made against Vifor International (AG)." NCLAT, which is an appellate authority over the orders passed by CCI, said Vifor International had the patent for Ferric Carboxymaltose (FCM) injection, which is required for the treatment of Iron Deficiency Anaemia (IDA). "The Patent Act will prevail over the Competition Act in the facts of this case,